book

Emerging Areas in Bioengineering

by Ho Nam Chang, Sang Yup Lee, Jens Nielsen, Gregory Stephanopoulos

March 2018

Intermediate to advanced

904 pages

29h 36m

English

Wiley-VCH

Read now

Unlock full access

1.1 Biotechnology1.2 Bioengineering1.3 Emerging Areas1.4 Current VolumeAcknowledgmentsReferences
2.1 Introduction2.2 Formation and Composition of IBs2.3 Enhancement of Protein Quality and Enzymatic Activity in IBs2.4 Applications of Enzyme-Based IBs2.5 An Example of IBs: N-acetyl-d-neuraminic Acid Aldolase2.6 Concluding RemarksAcknowledgmentsReferences
3.1 Introduction3.2 Enzymatic Reactions in Ionic Liquids3.3 Factors Affecting Enzymatic Reactions in Ionic Liquids3.4 Methods to Improve Enzyme Activity and Stability in Ionic Liquids3.5 Conclusions and PerspectivesAbbreviations of Ionic LiquidsReferences

4.1 Introduction4.2 Preparation of Enzyme-Immobilized Nanoparticles4.3 Application of Enzyme Nanoparticles4.4 Conclusion and PerspectivesReferences
Concise Definition of Subject5.1 Introduction5.2 GPI-Anchoring System5.3 C-Terminus Free Display Systems5.4 Applications of the Yeast Cell Surface Display System for Biocatalysts5.5 Improvement of Catalytic Activity on the Yeast Cell Surface5.6 ConclusionsReferences
Concise Definition of Subject6.1 Introduction6.2 Protein Assembly on a Template with Specific Interaction/Reaction Sites6.3 Protein Assembly without a Template: Self-Assembly of Protein Units6.4 Future ProspectsAcknowledgmentConflict of InterestReferences
7.1 Lignin and Its Composition7.2 Phenol Derivatives Derived from Lignin Deconstruction7.3 Biocatalysis to Increase the Value of Lignin-Derived Phenolic Compounds7.4 Outlook and Future PerspectivesAcknowledgmentsReferences
8.1 Introduction8.2 Sustainable Biomass for Sustainable Development8.3 Biorefineries and Bioenergy Conversion Pathways8.4 ConclusionsReferencesFurther Reading/Resources
9.1 Introduction and Characterization of Lignocellulosic Biomass in ASEAN Countries9.2 Forest Residues in ASEAN Countries9.3 Herbaceous Plants Residues in ASEAN Countries9.4 Agriculture Residue in ASEAN Countries9.5 ASEAN Government Programs and Policies on Natural BiomassReferences
10.1 Concept of Volatile Fatty Acid Platform10.2 Application of VFA Platform10.3 Tasks for CommercializationReferences
11.1 Introduction11.2 Pretreatments to Improve VFA Production11.3 Future Prospect and Recent Technology DevelopmentReferences
12.1 Introduction12.2 VFAs as a Carbon Source12.3 Quality of Yeast Lipid12.4 ConclusionAcknowledgmentsReferences
13.1 Introduction13.2 Gasification of Lignocellulosic Biomass13.3 Overview of Gasification Technologies of Lignocellulosic Biomass13.4 Classification of Gasification Technologies13.5 Types of Gasification Systems13.6 Performance Evaluation of Biomass Gasifiers13.7 Industrial Biomass Gasification Plants13.8 ConclusionReferences
14.1 Gas Stripping14.2 Liquid–Liquid Extraction14.3 Adsorption14.4 Pervaporation14.5 Distillation14.6 ConclusionReferences
15.1 Introduction15.2 Capturing of Inorganic Carbon Using Photosynthesis15.3 Microalgal Biofuel Production15.4 Application of Microalgal By-Products15.5 ConclusionReferences
16.1 Microbial Fuel Cells: General Concept and Extracellular Electron Transfer16.2 Electroactive Biofilm Meets with Biocompatible Materials16.3 Bioengineering of Electroactive Biofilm: From Bacteria to Ecosystem16.4 Conclusions and Future PerspectivesAcknowledgmentsReferences
17.1 Introduction17.2 Homologous Recombination-Mediated Tools17.3 Single-Strand DNA-Mediated Recombination17.4 ConclusionReferences
18.1 Introduction18.2 Synthetic Elements of Synthetic Biology for C. glutamicum18.3 Conclusion and OutlookReferences
19.1 Introduction19.2 Biomass and Its Metabolism19.3 Metabolic Engineering of Clostridia19.4 Concluding Remarks and Future PerspectivesReferences
AcknowledgmentsReferences
21.1 Metabolic Engineering21.2 Biological Production of Functional Food Materials21.3 Future ProspectsReferences
Concise Definition of Subject and Its Importance22.1 Lactic Acid Bacteria22.2 Expression Systems in LAB22.3 In silico Metabolic Pathway Model for LAB22.4 The Prospect: Lactic Acid Bacteria as an Edible Therapeutic ProbioticsReferences
23.1 Introduction23.2 Poly(butylene succinate)23.3 ConclusionReferences
24.1 Introduction24.2 Cultivation Strategies for a Few Important Bacterial InoculantsConflict of InterestReferences
25.1 Introduction25.2 Korean Herbal Medicine and Bioscience25.3 Bioprocessing of Natural Compounds in Traditional Herbal Medicine25.4 Skin Delivery Systems in Cosmetics25.5 ConclusionsReferences
26.1 Introduction26.2 Genetic Engineering of Microbial Reporter Cells26.3 Methods to Immobilize Cells and Maintain Cell Viability26.4 Microbial Biosensors Based on Transducers26.5 Conclusion and Future ProspectsAcknowledgmentsReferences
27.1 Introduction27.2 Concept of Bioelectronic Nose27.3 Primary Transducer for Bioelectronic Nose27.4 Secondary Transducer for Bioelectronic Nose27.5 Applications27.6 ConclusionAcknowledgmentReferences
28.1 Fluorescence Diagnosis of Skin or Mucosa28.2 Fluorescence Endoscopic Surgery28.3 Fluorescence Image-Guided Intraoperative Open Surgery28.4 ConclusionAcknowledgmentsReferences
29.1 DNA Sample Sources and Collection29.2 DNA Extraction from Biological Sources29.3 Short Tandem Repeat Markers and Commercial Kits29.4 Amplification of STR Loci29.5 Capillary Electrophoretic Separation of STR Amplicons29.6 Total Integrated Forensic STR Typing System29.7 ConclusionReferences
30.1 Allele-Specific Oligonucleotide Competitive Hybridization (ASOCH)30.2 Zip-Code Microarray30.3 Universal Amplification-Based Technology30.4 Bead Array Platform-Based SNP Genotyping30.5 ConclusionReferences
Chapter Outline31.1 Nanoscale Gravimetric Measuring System for Chiral Recognition31.2 Nanoscale Measuring System Using Two-Photon-Adsorbed Photopolymerization for Biosensors31.3 Nanoscale Measuring Systems Using AFM for Biosensors31.4 Nanoscale Measuring Systems with Nanoscale Motion DetectionReferences
Concise Definition of Subject32.1 Introduction32.2 Silver Nanoparticles32.3 Plants in Nanoparticle Synthesis32.4 Parameters Affecting Synthesis of AgNPs32.5 Mechanism of AgNP Synthesis32.6 Applications of AgNPs32.7 ConclusionReferences
33.1 Introduction33.2 External Drug Delivery Devices33.3 Internal Drug Delivery Implants33.4 Image-Guided Drug Delivery Systems33.5 Summary and PerspectivesAcknowledgmentsReferences
34.1 Introduction34.2 Drug Delivery Systems for Protein and Peptide Therapeutics34.3 Clinical Development of Protein and Peptide Delivery Systems34.4 Summary and PerspectivesReferences
35.1 Introduction to Cell-Based Therapeutics35.2 Biomaterials as Cell Delivery Vehicles35.3 Cell Delivery Strategies35.4 Conclusion and Future PerspectiveReferences
36.1 Introduction36.2 Prokaryotic Cell-Derived Nanocarriers36.3 Eukaryotic Cell-Derived Nanocarriers36.4 Cell Membrane-Camouflaged Nanoparticles36.5 ConclusionsAcknowledgmentsReferences
Concise Definition of the Subject37.1 Background37.2 Fc-Fusion Technology37.3 Albumin Fusion Technology37.4 Transferrin Fusion Technology37.5 CTP Fusion Technology37.6 SummaryReferences
38.1 Introduction38.2 Synthetic and Natural Polymer-Based Mussel-Mimetic Biomaterials38.3 Tissue Adhesives38.4 Biomolecule Immobilization and Drug Delivery38.5 Concluding RemarksAcknowledgmentsReferences
39.1 Mass Production of Biosimilar Monoclonal Antibodies in Mammalian Cells39.2 Mass Production of Monoclonal Antibodies in Yeast39.3 Mass Production of Monoclonal Antibodies in Escherichia coli39.4 ConclusionReferences
Concise Definition of Subject40.1 Introduction40.2 MS-Based Proteomic Analysis Pipeline for Discovery of Protein Biomarkers40.3 Discovery of Protein Biomarkers Using LC–MS/MS Analysis40.4 Analysis of Proteomic Data for the Biomarker Discovery40.5 Verification and Validation of Biomarker CandidatesReferences
41.1 Introduction41.2 Modeling and Design of Bioprocess41.3 Monitoring of Bioprocess41.4 Control of Bioprocess41.5 Computational Fluid Dynamics in Bioprocess SimulationReferences
42.1 The Purpose of Bioprocess Simulation42.2 Detailed Modeling of Single Batch Bioprocesses42.3 Design and Operation of Multiproduct Facilities42.4 ConclusionAbbreviationsReferences
43.1 Introduction43.2 Growth Model Construction and a Diversity of Modification Methods43.3 Optimal Decision-Making System43.4 Case Study43.5 SummaryAcknowledgmentsReferences
44.1 Introduction44.2 COBRA Framework44.3 COBRA Software Applications44.4 Utilizing the Potential of COBRA Software Applications Suite: A Practical Case Study44.5 Conclusions and Future PerspectivesReferences
45.1 Biological Computer-Aided Design of Interactions45.2 Community Metabolic Network Reconstruction45.3 Prediction of Interactions Using Metabolic Networks45.4 ConclusionsAcknowledgmentsConflicts of InterestReferences

Content preview from Emerging Areas in Bioengineering

Chapter 33Smart Drug Delivery Devices and Implants

Ki Su Kim, Ho Sang Jung, Hyunsik Choi, Songeun Beack, Hyemin Kim, Jong Hwan Mun, Myeong Hwan Shin, Do Hee Keum, Heebeom Koo, Seok Hyun Yun and Sei Kwang Hahn

33.1 Introduction

Recently, a variety of drug delivery devices (DDDs) have been extensively investigated for the spatiotemporal control of drugs in the body. For example, some researchers have investigated DDDs, taking advantages of new electronic or computer devices. These smart DDDs can display or transfer the information on the disease site effectively and enable suitable feedback for drug delivery while monitoring the therapeutic results [1]. In comparison with the conventional drug delivery systems (DDSs), the DDDs have the advantages ...